Main genomics and biopharmaceutical specialist Malaysian Genomics Useful resource Centre (MGRC) Berhad has signed a letter of intent (LOI) with The school of Science and Pure Useful assets, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on evaluation and enchancment (R&D) in genetics, and regenerative and various medicines.
Beneath the LOI, MGRC, which owns a extreme-throughput sequencing lab, superior microarray facility, and new state-of-the-artwork cell processing lab, As properly as to Genotec, which Focuses on biomedical cures using stem cells, will assist in strengthening the educating and evaluation actions of the undergraduate programme at UMS’ Faculty of Science and Pure Useful assets.
This cooperation will allow the commerce of evaluation assets And ideas To reinforce The regular of evaluation at UMS, As properly as to create alternatives For school youngsters from The school of Science and Pure Useful assets to serve their internship interval at MGRC or Genotec.
Chairman of Malaysian Genomics, Datuk Seri Dr Chen Chaw Min, said, “We’re joyful To assist UMS undergraduates in pursuing their R&D goals So as that They’ve A greater understanding of their area of research. That May even be in assist of the Nationwide Biotechnology Coverage 2.0 launched recently Specializing in agriculture and meals safety, healthcare and properlybeing, As properly as to industrial and the round financial system.”
The signing of the LOI adopted UMS’ go to to MGRC’s Biosafety Diploma 2 cGMP (Current Good Manufacturing Apply)-licensed laboratory, which is used for the manufacturing of cell therapies, collectively with Automotive T-cell therapies for numerous cancers.
Comment here